Patients with mild asthma commonly rely on short-term relievers vs long-term controller medication. To evaluate a new as-needed medication for asthma control, researchers conducted a randomized, clinical...
Researchers analyzed the safety and efficacy of a fully human anti-IL-4 receptor α monoclonal antibody for the treatment of late-onset asthma and fixed airway obstruction.
Respiratory tract infections are a risk factor for exacerbations among elderly patients with asthma. However, there are no treatments available to reduce these infections among this high-risk group. Results...
Opioid misuse has become an epidemic in the United States. This new analysis evaluated whether hospital-administered opioids lead to an increase in opioid prescriptions after discharge.
It is well known that cigarettes increase the risk for viral infections like influenza, and e-cigarettes suppress the immune system in the respiratory tract. But how does innate immune suppression in the...
Following a randomized trial, researchers believe that they have found an as-needed alternative to budesonide maintenance therapy for the management of mild asthma.
Because blood eosinophil count has been shown to be associated with certain pneumonia risk factors, researchers examined whether it could be used to predict pneumonia risk in COPD patients with various FEV1...
The authors of a recent study aimed to investigate the long-term effects of proton pump inhibitor use on the incidence of pneumonia among older adults in primary care.
During this keynote session at the American Lung Association’s LUNGFORCE Expo, Dr Thomas Bauer II explained who is included in his multidisciplinary team, how this team works together to manage patients...
